ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 923

Neutrophils from Children with Systemic JIA Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease

Rachel Brown1, Maggie Henderlight1, Thuy Do1, Shima Yasin2, Monica DeLay1, Alexei A. Grom3,4 and Grant Schulert2,5, 1Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Rheumatology, Divisions of Rheumatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 3Pediatrics, University of Cincinnati, CINCINNATI, OH, 4Rheumatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 5Pediatrics, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: IL-1/IL-18, macrophage activation syndrome and neutrophils, Systemic JIA

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, October 21, 2018

Title: 3S106 ACR Abstract: Pediatric Rheumatology–Basic Science (922–927)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Systemic juvenile idiopathic arthritis (SJIA) is a chronic childhood arthropathy with features of autoinflammation. New-onset SJIA is associated with expansion and activation of neutrophils with a sepsis-like phenotype, but neutrophil phenotypes in longstanding and clinically inactive disease (CID) is unknown. The objective of this study was to examine activated neutrophil subsets, S100 alarmin release, and gene expression signatures in children with a spectrum of SJIA disease activity.

Methods: This protocol was approved by the Institutional Review Board, and informed consent was obtained from all patients and/or their legal guardians. Highly-purified neutrophils were isolated using a two-step procedure of density-gradient centrifugation followed by magnetic-bead based negative selection using the MACSexpress kit. Neutrophils were then stained for imaging flow cytometry, or RNA isolated was using MagMax Total RNA Isolation Kit. Alternatively, neutrophils were cultured for 4hr with or without PMA to quantify S100 protein release. Gene expression analysis was performed with the Ampliseq Transcriptome kit using the Ion Torrent platform.

Results: Patients with SJIA and active systemic features demonstrated a higher number of the immunosuppressive subset CD16+CD62Llo neutrophils compared to controls. This neutrophil subset was not seen in patients with inactive disease or those with active arthritis only without systemic features. Using imaging flow cytometry, CD16+CD62Llo neutrophils from patients with active SJIA had mildly increased nuclear hypersegmentation compared to CD16+CD62L+ neutrophils. Serum levels of S100A8/A9 and S100A12 were strongly correlated with peripheral blood neutrophil count (R=0.53 and R=0.64, respectively; p<0.001). Neutrophils from active SJIA patients cultured in vitro did not show enhanced resting S100 protein release compared to inactive disease or control neutrophils. However, regardless of disease activity, neutrophils from SJIA patients did show enhanced S100A8/A9 release upon PMA stimulation compared to control neutrophils (P<0.05). Whole transcriptome analysis of highly purified neutrophils from children with active SJIA identified 214 differentially expressed genes compared to control neutrophils (fold change >2.0, p<0.05). The most significantly upregulated gene pathway was Immune System Process (adjusted p=3.4×10-16) including AIM2, IL18RAP, NLRC4, TLR2, TLR5, and TNFAIP3. Interestingly, this gene set showed intermediate levels of expression in neutrophils from patients with long-standing inactive disease but persistent serum IL-18 elevation. Indeed, all patient samples regardless of disease activity demonstrated elevated inflammatory gene expression, including inflammasome components and S100A8.

Conclusion: We identify features of neutrophil activation in SJIA, including a proinflammatory gene expression signature in patients with longstanding CID but elevated serum IL-18, reflecting persistent innate immune activation. Taken together, these studies expand understanding of neutrophil function in chronic autoinflammatory disorders such as SJIA.


Disclosure: R. Brown, None; M. Henderlight, None; T. Do, None; S. Yasin, None; M. DeLay, None; A. A. Grom, Novartis, 2,AB2Bio, 2,NovImmune, 2; G. Schulert, None.

To cite this abstract in AMA style:

Brown R, Henderlight M, Do T, Yasin S, DeLay M, Grom AA, Schulert G. Neutrophils from Children with Systemic JIA Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/neutrophils-from-children-with-systemic-jia-exhibit-persistent-proinflammatory-activation-despite-long-standing-clinically-inactive-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/neutrophils-from-children-with-systemic-jia-exhibit-persistent-proinflammatory-activation-despite-long-standing-clinically-inactive-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology